HELPING THE GLOBAL BIOSIMILAR INDUSTRY BRING BIOSIMILARS TO THE US
The World Biosimilar Congress USA 2016 brought together the largest gathering of biosimilar stakeholders – including PBMs and payers – and drove the conversation forward on the future of biosimilars in the United States.
This May, the 2017 edition will raise the bar, with an extended agenda including two dedicated streams – one for the analytical and manufacturing challenges that still exist on the scientific end, and one for the business and strategic side. As more companies begin to expand their pipelines and seek FDA approval, discussion topics in this space allow us to dive deeper into the science of biosimilar development, and all of the challenges that come along with it.
2017 Speakers Include:
- Richard DiCicco, Chairman, Harvest Moon Pharmaceuticals
- Chrys Kokino, Head, Global Biologics, Commercial, Merck Serono
- Javier Condreau, Vice-President Global Medical Affairs and Biosimilars, Pfizer
- Niraj Chhaya, Lead Risk Management, Global Pharmacovigilance, Boehringer Ingelheim Pharma GmbH & Co. KG
This event is co-located with Americas Antibody Congress 2017, Cell Culture World Congress USA 2017, and World Immunotherapy Congress USA 2017.
<< Visit the event website to register now
For more information, contact Aidan Brain at aidan.brain@terrapinn.com or +1 646 619 1776